1. Home
  2. CDIO vs BNRG Comparison

CDIO vs BNRG Comparison

Compare CDIO & BNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDIO
  • BNRG
  • Stock Information
  • Founded
  • CDIO 2017
  • BNRG 2012
  • Country
  • CDIO United States
  • BNRG Israel
  • Employees
  • CDIO N/A
  • BNRG N/A
  • Industry
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • BNRG
  • Sector
  • CDIO Health Care
  • BNRG
  • Exchange
  • CDIO Nasdaq
  • BNRG Nasdaq
  • Market Cap
  • CDIO 6.4M
  • BNRG 5.2M
  • IPO Year
  • CDIO N/A
  • BNRG 2022
  • Fundamental
  • Price
  • CDIO $3.76
  • BNRG $2.06
  • Analyst Decision
  • CDIO
  • BNRG
  • Analyst Count
  • CDIO 0
  • BNRG 0
  • Target Price
  • CDIO N/A
  • BNRG N/A
  • AVG Volume (30 Days)
  • CDIO 29.6K
  • BNRG 72.8K
  • Earning Date
  • CDIO 08-14-2025
  • BNRG 08-13-2025
  • Dividend Yield
  • CDIO N/A
  • BNRG N/A
  • EPS Growth
  • CDIO N/A
  • BNRG N/A
  • EPS
  • CDIO N/A
  • BNRG N/A
  • Revenue
  • CDIO $19,507.00
  • BNRG N/A
  • Revenue This Year
  • CDIO $1,434.82
  • BNRG N/A
  • Revenue Next Year
  • CDIO $4,661.91
  • BNRG N/A
  • P/E Ratio
  • CDIO N/A
  • BNRG N/A
  • Revenue Growth
  • CDIO N/A
  • BNRG N/A
  • 52 Week Low
  • CDIO $3.22
  • BNRG $1.64
  • 52 Week High
  • CDIO $53.10
  • BNRG $15.30
  • Technical
  • Relative Strength Index (RSI)
  • CDIO 47.81
  • BNRG 49.55
  • Support Level
  • CDIO $3.62
  • BNRG $1.97
  • Resistance Level
  • CDIO $3.99
  • BNRG $2.24
  • Average True Range (ATR)
  • CDIO 0.27
  • BNRG 0.15
  • MACD
  • CDIO 0.03
  • BNRG 0.01
  • Stochastic Oscillator
  • CDIO 68.00
  • BNRG 21.95

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

About BNRG Brenmiller Energy Ltd

Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.

Share on Social Networks: